Entries by Katja Stout

LSX World Congress Plenary Panel – Biotech in 2022: Another wave or low tide?

McKinsey’s Alexandra Zemp and Rachel Moss presented intriguing data and provided timely insights on where they see the markets, currently in turmoil, may go in 2022. The McKinsey partners opened with frightening stats that the biotech public markets have declined 36% since 1 Sept 2021 to May 2022. The IPO window has narrowed significantly, with […]

Let the Northern Lights Illuminate your BIO-Europe® Partnering

Making a plan for BIO-Europe® Digital in October? This time around we were almost going to be in Stockholm, one of the glittering capitals in the Nordics. But the world doesn’t seem quite ready to kick off its comfy Zoom slippers and try on some new work shoes to walk the walk, as well as talk the talk, for […]